2,417
Views
20
CrossRef citations to date
0
Altmetric
REVIEW

Drug delivery and nanodetection in lung cancer

, , , , , & show all
Pages 618-634 | Received 24 Sep 2014, Accepted 07 Oct 2014, Published online: 11 Nov 2014

References

  • Ahmadi A, Shirazi H, Pourbagher N, Akbarzadeh A, Omidfar K. 2014. An Electrochemical Immunosensor for Digoxin Using Core-Shell Gold Coated Magnetic Nanoparticles as Labels. Mol Biol Rep. 41:1659–1668.
  • Akbarzadeh A, Samiei M, Davaran S. 2012. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett. 7:144.
  • Alberg AJ, Brock MV, Samet JM. 2005. Epidemiology of lung cancer: looking to the future. J Clin Oncol. 23:3175–3185.
  • Alberg AJ, Samet JM. 2003. Epidemiology of lung cancer. Chest. 123:21S–49S.
  • Azarmi S, Roa WH, Löbenberg R. 2008. Targeted delivery of nanoparticles for the treatment of lung diseases. Adv Drug Deliv Rev. 60: 863–875.
  • Azzazy HME, Mansour MMH, Kazmierczak SC. 2007. From diagnostics to therapy: prospects of quantum dots. Clin Biochem. 40:917–927.
  • Baptista PV. 2009. Cancer Nanotechnology-Prospects for Cancer Diagnostics and Therapy. Curr Can Ther Rev. 5:80–88.
  • Bianco A, Kostarelos K, Prato M. 2005. Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol. 9:674.
  • Biju V, Itoh T, Anas A, Sujith A, Ishikawa M. 2008. Semiconductor quantum dots and metal nanoparticles: syntheses, optical properties, and biological applications. Anal Bioanal Chem. 391:2469–2495.
  • Blanco E, Bey EA, Khemtong C, Yang SG, Setti-Guthi J, Chen H, et al. 2010. β-lapachone micellar nanotherapeutics for non–small cell lung cancer therapy. Cancer Res. 70:3896–3904.
  • Cai W, Gao T, Hong H, Sun J. 2008. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl. 1:17–32.
  • Chan WCW, Nie S. 1998. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science. 281:2016–2018.
  • Chen J, Chen S, Zhao X, Kuznetsova LV, Wong SS, Ojima I. 2008. Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery. J Am Chem Soc. 130:16778–85.
  • Chen L. 2004. Development and characterization of controlled drug delivery using nanoparticles. Thesis (M.S.) University of New Orleans.
  • Chen Y-S, Hung YC, Liau I, Huang GS. 2009. Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res Lett. 4:858–864.
  • Conde J, Doria G, Baptista P. 2011. Noble metal nanoparticles applications in cancer. J Drug Deliv. 2012 :751075.
  • Conti M, Tazzari V, Baccini C, Pertici G, Serino LP, De Giorgi U. 2006. Anticancer drug delivery with nanoparticles. In Vivo. 20: 697–701.
  • Cotugno R, Fortunato R, Santoro A, Gallotta D, Braca A, De Tommasi N, Belisario MA. 2012. Effect of sesquiterpene lactone coronopilin on leukaemia cell population growth, cell type‐specific induction of apoptosis and mitotic catastrophe. Cell Prolif. 45:53–65.
  • Cuenca AG, Jiang H, Hochwald SN, Delano M, Cance WG, Grobmyer SR. 2006. Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer. 107:459–466.
  • Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. 2012. PLGA-based nanoparticles: An overview of biomedical applications. J Control Release. 161:505–522.
  • Davaran S, Akbarzadeh A, Nejati-Koshki K, Alimohammadi S, Ghamari MF, Soghrati MM, Rezaei A, Khandaghi AA. 2013. In Vitro Studies of NIPAAM-MAA-VP Copolymer-Coated Magnetic Nanoparticles for Controlled Anticancer Drug Release. J Encapsul Adsorption Sciences. 3:108–115.
  • De Jong WH, Borm PJA. 2008. Drug delivery and nanoparticles: applications and hazards. Inter J Nanomedicine. 3:133.
  • Depierre A, Milleron B, Moro-Sibilot D, Chevret S, Quoix E, Lebeau B, et al. 2002. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non–small-cell lung cancer. J Clin Oncol. 20:247–253.
  • Dienemann H. 2001. Principles of surgical treatment in localized non-small cell lung cancer. Lung Cancer. 33:S3–S8.
  • Digge MS, Moon RS, Gattani SG. 2012. Application of Carbon Nanotubes in Drug Delivery: A Review. Int J Pharm Tech Res. 4:839–847.
  • Dua JS, Rana AC, Bhandari AK. 2012. Liposome: Methods of Preparation and Applications. IJPSR. 3:14–20.
  • Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. 2002. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science. 298:1759–1762.
  • Duncan B, Kim C, Rotello VM. 2010. Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J Control Release. 148:122–127.
  • Fanfair D, Desai S, Kelty C. 2007. The early history of nanotechnology. Connexions. 6.
  • Fong KM., Yang IA, Zimmerman PV, Bowman RV. 2005. Cochrane systematic reviews of treatments for lung cancer. Respir Med. 99:1071–1078.
  • Ganti AK, Mulshine JL. 2006. Lung cancer screening. Oncologist. 11:481–487.
  • Gao L, Wang Z, Li F, Hammoudi AA, Thrall MJ, Cagle PT, Wong ST. 2012. Differential Diagnosis of Lung Carcinoma With Coherent Anti-Stokes Raman Scattering Imaging. Arch Pathol Lab med. 136:1502–1510.
  • Gaspar MM, Radomska A, Gobbo OL, Bakowsky U, Radomski MW, Ehrhardt C. 2012. Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats. J Aerosol Med Pulm Drug Deliv. 25:310–318.
  • Ghasemi Y, Peymani P, Afifi S. 2009. Quantum dot: magic nanoparticle for imaging, detection and targeting. Acta Biomed. 80:156–165.
  • Gillies ER, Frechet JMJ. 2005. Dendrimers and dendritic polymers in drug delivery. Drug Discovery Today. 10:35–43.
  • Gomathi M, Thangaraj P. 2010. A computer aided diagnosis system for detection of lung cancer nodules using extreme learning machine. International Journal of Engineering Science and Technology. 2:5770–5779.
  • Gordon SM, Szidon JP, Krotoszynski BK, Gibbons RD, O’Neill HJ. 1985. Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem. 31:1278–1282.
  • Guessous I, Cornuz J, Paccaud F. 2007. Lung cancer screening: current situation and perspective. Swiss Medical Weekly. 137:304–11.
  • Hardman R. 2006. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect. 114:165.
  • Heath JR, Davis ME. 2008. Nanotechnology and cancer. Annu Rev Med. 59:251–265.
  • Heister E, Neves V, Tîlmaciu C, Lipert K, Beltrán VS, Coley HM, et al. 2009. Triple functionalisation of single-walled carbon nanotubes with doxorubicin, a monoclonal antibody, and a fluorescent marker for targeted cancer therapy. Carbon. 47:2152–2160.
  • Horvath I, Lázár Z, Gyulai N, Kollai M, Losonczy G. 2009. Exhaled biomarkers in lung cancer. Eur Respir J. 34:261–275.
  • Hou PX, Bai S, Yang QH, Liu C, Cheng HM. 2002. Multi-step purification of carbon nanotubes. Carbon. 40:81–85.
  • Huang X, El-Sayed IH, El-Sayed MA. 2010. Applications of gold nanorods for cancer imaging and photothermal therapy. Methods Mol. Biol. 624:343–357.
  • Hureaux J, Lagarce F, Gagnadoux F, Vecellio L, Clavreul A, Roger E, et al. 2009. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel. Eur J Pharm Biopharm. 73:239–246.
  • Iijima S. 1991. Helical microtubules of graphitic carbon. Nature. 354:56–58.
  • Immordino ML, Dosio F, Cattel L. 2006. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine. 1:297.
  • Indira TK, Lakshmi PK. 2010. Magnetic nanoparticles—a review. Inter J Pharm Sci Nanotechnol. 3.
  • Ito A, Shinkai M, Honda H, Kobayashi T. 2005. Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng. 100:1–11.
  • Jamieson T, Bakhshi R, Petrova D, Pocock R, Imani M, Seifalian AM. 2007. Biological applications of quantum dots. Biomaterials. 28:4717–4732.
  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J Clin. 61:69–90.
  • Ji S-R, Liu C, Zhang B, Yang F, Xu J, Long J, et al. 2010. Carbon nanotubes in cancer diagnosis and therapy. Biochim Biophys Acta. 1806:29–35.
  • Jin, S., Hu YX, Gu ZJ, Liu L, Wu HC. 2011. Application of quantum dots in biological imaging. Journal of Nanomaterials. 2011:12.
  • Jones M-C, Leroux J-C. 1999. Polymeric micelles–a new generation of colloidal drug carriers. Eur J Pharm Biopharm. 48:101–111.
  • Justo OR, Moraes ÂM. 2003. Incorporation of antibiotics in liposomes designed for tuberculosis therapy by inhalation. Drug Deliv. 10: 201–207.
  • Kaskowitz L, Graham MV, Emami B, Halverson KJ, Rush C. 1993. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 27:517–523.
  • Kim DW, Kim SY, Kim HK, Kim SW, Shin SW, Kim JS, et al. 2007. Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Annals of oncology. 18:2009–2014.
  • Konkar A, Lu S, Madhukar A, Hughes SM, Alivisatos AP. 2005. Semiconductor nanocrystal quantum dots on single crystal semiconductor substrates: high resolution transmission electron microscopy. Nano Lett. 5:969–973.
  • Kurmi BD, Gajbhiye V, Kayat J, Jain NK. 2011. Lactoferrin‐conjugated dendritic nanoconstructs for lung targeting of methotrexate. J Pharm Sci. 100:2311–2320.
  • Lam S, Lam B, Petty TL. 2001. Early detection for lung cancer. New tools for casefinding. Can Fam Physician. 47:537–544.
  • Leutwyler WK, Bürgi SL, Burgl HB. 1996. Semiconductor clusters, nanocrystals, and quantum dots. Science. 271:933.
  • Liu J, Chu L, Wang Y, Duan Y, Feng L, et al. 2011a. Novel peptide– dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer. Inter J Nanomedicine. 6:59.
  • Liu R, Gan L, Yang X, Xu H. 2011b. Chitosan as a condensing agent induces high gene transfection efficiency and low cytotoxicity of liposome. J Biosci Bioeng. 111:98–103.
  • Ma J, Fan Q, Wang L, Jia N, Gu Z, Shen H. 2010. Synthesis of magnetic and fluorescent bifunctional nanocomposites and their applications in detection of lung cancer cells in humans. Talanta. 81:1162–1169.
  • Markides H, Rotherham M, El Haj AJ. 2012. Biocompatibility and Toxicity of Magnetic Nanoparticles in Regenerative Medicine. J Nanomater.
  • Minati L, Antonini V, Dalla Serra M, Speranza G. 2012. Multifunctional Branched Gold–Carbon Nanotube Hybrid for Cell Imaging and Drug Delivery. Langmuir. 28:15900–15906.
  • Miyata K, James Christie R, Kataoka K. 2010. Polymeric micelles for nano-scale drug delivery. React Funct Polym.
  • Mody HR. 2011. Cancer nanotechnology: Recent trends and developments. Internet J Med Update-EJOURNAL. 6.
  • Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. 2008. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
  • Mozafari M, Pardakhty A, Azarmi S, Jazayeri JA, Nokhodchi A, Omri A. 2009. Role of nanocarrier systems in cancer nanotherapy. J Liposome Res. 19:310–321.
  • Nakanishi T, Fukushima S, Okamoto K, Suzuki M, Matsumura Y, Yokoyama M et al. 2001. Development of the polymer micelle carrier system for doxorubicin. J Control Release. 74: 295–302.
  • Nishiyama N, Kataoka K. 2006. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther. 112:630–648.
  • Okunaka T, Kato H, Tsutsui H, Ishizumi T, Ichinose S, Kuroiwa Y. 2004. Photodynamic therapy for peripheral lung cancer. Lung Cancer. 43:77–82.
  • Park K, Lee S, Kang E, Kim K, Choi K, Kwon IC. 2009a. New generation of multifunctional nanoparticles for cancer imaging and therapy. Adv Funct Mater. 19:1553–1566.
  • Park C, Youn H, Kim H, Noh T, Kook YH, Oh ET, et al. 2009b. Cyclodextrin-covered gold nanoparticles for targeted delivery of an anti-cancer drug. J. Mater. Chem. 19:2310–2315.
  • Pastorino U. 2006. Early detection of lung cancer. Respiration. 73: 5–13.
  • Patton JS, Byron PR. 2007. Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov. 6:67–74.
  • Peng G, Trock E, Haick H. 2008. Composites of carbon nanotubes and non-polymeric materials for diagnosing lung cancer via breath samples. International Society for Optics and Photonics.
  • Pourhassan-Moghaddam M, Rahmati-Yamchi M, Akbarzadeh A, Daraee H, Nejati-Koshki K, Hanifehpour Y, Joo SW. 2013. Protein Detection through Different Platforms of Immuno-Loop-Mediated Isothermal Amplification. Nanoscale Res Lett. 8:485.
  • Preti G, Labows JN, Kostelc JG, Aldinger S, Daniele R. 1988. Analysis of lung air from patients with bronchogenic carcinoma and controls using gas chromatography-mass spectrometry. J Chromatogr. 432:1–11.
  • Qian X, Peng XH, Ansari DO, Yin-Goen Q, Chen GZ, Shin DM, et al. 2007. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol. 26:83–90.
  • Quintana A, Raczka E, Piehler L, Lee I, Myc A, Majoros I, et al. 2002. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res. 19:1310–1316.
  • Ramalingam S, Belani C. 2008. Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions. Oncologist. 13:5–13.
  • Rana S, Bajaj A, Mout R, Rotello VM. 2012. Monolayer coated gold nanoparticles for delivery applications. Adv Drug Deliv Rev. 64:200–216.
  • Ray M, Salgia R, Vokes EE. 2009. The role of EGFR inhibition in the treatment of non-small cell lung cancer. Oncologist. 14:1116–1130.
  • Sadat TMF, Akbarzadeh A, Zarghami N, Zeighamian V, Rahimzadeh A, Alimohammadi S. 2014. PLGA-cased nanoparticles as cancer drug delivery systems. Asian Pac J Cancer Prev. 15:517–535.
  • Sajja HK, East MP, Mao H, Wang YA, Nie S, Yang L. 2009. Development of Multifunctional Nanoparticles for Targeted Drug Delivery and Non-invasive Imaging of Therapeutic Effect. Curr Drug Discov Technol. 6:43.
  • Savić R, Luo L, Eisenberg A, Maysinger D. 2003. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science. 300: 615–618.
  • Shenoy D, Fu W, Li J, Crasto C, Jones G, DiMarzio C, et al. 2006. Surface functionalization of gold nanoparticles using hetero-bifunctional poly (ethylene glycol) spacer for intracellular tracking and delivery. Inter J Nanomedicine. 1:51.
  • Sher T, Dy GK, Adjei AA. 2008. Small cell lung cancer. Mayo Clin Proc. 83:355–367
  • Silva GA. 2004. Introduction to nanotechnology and its applications to medicine. Surg Neurol. 61:216–220.
  • Singh R, Lillard JW Jr. 2009. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 86:215–223.
  • Sung JC, Pulliam BL, Edwards DA. 2007. Nanoparticles for drug delivery to the lungs. Trends Biotechnol. 25:563–570.
  • Sutedja G. 2003. New techniques for early detection of lung cancer. Euro Respi J. 21:57s–66s.
  • Tartaj P, del Puerto Morales M, Veintemillas-Verdaguer S, González-Carreno T, Serna CJ. 2003. The preparation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys. 36:R182.
  • Tiwari PM, Vig K, Dennis VA, Singh SR. 2011. Functionalized gold nanoparticles and their biomedical applications. Nanomaterials. 1:31–63.
  • Tomoda K, Ohkoshi T, Hirota K, Sonavane GS, Nakajima T, Terada H, et al. 2009. Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer. Colloids Surf B Biointerfaces. 71:177–182.
  • Ukraintseva SV, Arbeev KG, Yashin AI. 2008. Epidemiology of hormone-associated cancers as a reflection of age. Adv Exp Med Biol. 57–71.
  • Valizadeh A, Mikaeili H, Samiei M, Farkhani SM, Zarghami N, Kouhi M. 2012. Quantum dots: synthesis, bioapplications, and toxicity. Nanoscale Res Lett. 7:480.
  • Wang Y, Zhang Y, Du Z, Wu M, Zhang G. 2012. Detection of micrometastases in lung cancer with magnetic nanoparticles and quantum dots. Int J Nanomedicine. 7:2315.
  • Warner E, Jotkowitz A, Maimon N. 2010. Lung cancer screening–are we there yet? Eur J Intern Med. 21:6–11.
  • White SC, Lorigan P, Margison GP, Margison JM, Martin F, Thatcher N. 2006. Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer. Br J Cancer. 95:822–828.
  • Yang W, Peters JI, Williams RO. 2008. Inhaled nanoparticles—a current review. Int J Pharm. 356:239–247.
  • Yokoyama M, Okano T, Sakurai Y, Kataoka K. 1994. Improved synthesis of adriamycin-conjugated poly (ethylene oxide)-poly (aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin. J Controlled Release. 32:269–277.
  • Yokoyama M, Sugiyama T, Okano T, Sakurai Y, Naito M, Kataoka K. 1993. Analysis of micelle formation of an adriamycin-conjugated poly (ethylene glycol)–poly (aspartic acid) block copolymer by gel permeation chromatography. Pharm Res. 10:895–899.
  • Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. 2007. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 83:761–769.
  • Zhang X, Meng L, Lu Q, Fei Z, Dyson PJ. 2009. Targeted deli- very and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. Biomaterials. 30: 6041–6047.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.